ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

PHIO Company Profile and Key Details

NASDAQ : PHIO

Phio Pharmaceuticals Corp.

$1.33

-0.02-1.48%

At Close 4:00 PM

56.64

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

PHIO Stock Price Chart

Stock Price Today

Phio Pharmaceuticals Corp. (PHIO) stock declined over -1.48%, trading at $1.33 on NASDAQ, down from the previous close of $1.35. The stock opened at $1.36, fluctuating between $1.32 and $1.44 in the recent session.

Stock Snapshot

1.35

Prev. Close

1.36

Open

6.35M

Market Cap

4.78M

Number of Shares

1.32

Day Low

1.44

Day High

-0.14

P/E Ratio

98.46%

Free Float in %

-9.75

EPS (TTM)

2.06

Book Value

-2.87

Cash Flow per Share

194.56K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 13, 2025	1.36	1.44	1.32	1.33	195.58K
Mar 12, 2025	1.31	1.37	1.24	1.35	127.08K
Mar 11, 2025	1.29	1.33	1.26	1.30	73.79K
Mar 10, 2025	1.29	1.33	1.27	1.29	55.09K
Mar 07, 2025	1.36	1.37	1.26	1.30	90.12K
Mar 06, 2025	1.32	1.40	1.30	1.34	146.91K
Mar 05, 2025	1.36	1.44	1.30	1.39	249.26K
Mar 04, 2025	1.33	1.35	1.22	1.32	193.3K
Mar 03, 2025	1.40	1.43	1.31	1.32	141K
Feb 28, 2025	1.45	1.45	1.36	1.42	95.94K
Feb 27, 2025	1.50	1.52	1.43	1.43	100.5K
Feb 26, 2025	1.42	1.52	1.42	1.49	110.77K
Feb 25, 2025	1.56	1.61	1.43	1.47	290.68K
Feb 24, 2025	1.66	1.69	1.56	1.57	167.42K
Feb 21, 2025	1.73	1.74	1.65	1.67	82.9K
Feb 20, 2025	1.73	1.75	1.69	1.72	104.93K
Feb 19, 2025	1.65	1.78	1.64	1.74	200.39K
Feb 18, 2025	1.77	1.84	1.67	1.70	303.54K
Feb 14, 2025	1.83	1.88	1.79	1.81	257.85K
Feb 13, 2025	1.80	1.86	1.76	1.79	169.31K

Contact Details

Marlborough, MA 01752

United States

Website: https://www.phiopharma.comContact: 508 767 3861

About Company

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for use in ACT. It has collaborations with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Frequently Asked Questions

What is the current Phio Pharmaceuticals Corp. (PHIO) stock price?

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) stock price is $1.33 in the last trading session. During the trading session, PHIO stock reached the peak price of $1.44 while $1.32 was the lowest point it dropped to. The percentage change in PHIO stock occurred in the recent session was -1.48% while the dollar amount for the price change in PHIO stock was -$0.02.

PHIO's industry and sector of operation?

The NASDAQ listed PHIO is part of Biotechnology industry that operates in the broader Healthcare sector. Phio Pharmaceuticals Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PHIO?

Ms. Linda M. Mahoney
Senior Vice President of Devel.
Ms. Caitlin Kontulis
Vice President of Fin. & Admin. and Sec.
Mr. Robert J. Bitterman
Pres, Chief Executive Officer & Chairman

How PHIO did perform over past 52-week?

PHIO's closing price is 9.02% higher than its 52-week low of $1.22 where as its distance from 52-week high of $9.99 is -86.69%.

How many employees does PHIO have?

Number of PHIO employees currently stands at 8.

Link for PHIO official website?

Official Website of PHIO is: https://www.phiopharma.com

How do I contact PHIO?

PHIO could be contacted at phone 508 767 3861 and can also be accessed through its website. PHIO operates from 257 Simarano Drive, Marlborough, MA 01752, United States.

How many shares of PHIO are traded daily?

PHIO stock volume for the day was 194.56K shares. The average number of PHIO shares traded daily for last 3 months was 6.7M.

What is the market cap of PHIO currently?

The market value of PHIO currently stands at $6.35M with its latest stock price at $1.33 and 4.78M of its shares outstanding.

Employees	8
Beta	1.27
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology